Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-11

Clinical Trial Results: Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial results for venetoclax and azacitidine in non-elderly adults with acute myeloid leukemia (AML) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • venetoclax and azacitidine

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2026-06-11